ArticleLa Radiologia medica2026
Spectral CT-based intratumoral and peritumoral radiomics for predicting invasiveness of ground-glass nodules in lung adenocarcinoma.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesTo evaluate the potential of spectral detector computed tomography (SDCT) combined with intratumoral and peritumoral radiomics for noninvasive characterization of lung adenocarcinomas (LUAD) presenting as ground-glass nodules (GGNs).
methodsThis retrospective multicenter study included patients from two centers. In Center 1, 241 patients with GGNs (adenocarcinoma in situ [AIS], n = 42; minimally invasive adenocarcinoma [MIA], n = 138; invasive adenocarcinoma [IAC], n = 61) were randomly split into training and test sets (7:3). Center 2 served as an external validation cohort including 87 patients (AIS, n = 35; MIA, n = 27; IAC, n = 25). All patients underwent unenhanced dual-layer SDCT examinations. Radiomics features were extracted from intratumoral and peritumoral regions (1-5 mm) based on SDCT-derived conventional polychromatic images (CPI), effective atomic number (Z
resultsAmong all peritumoral models, the 2 mm peritumoral multiparameter fusion model showed the best performance, with macro-average AUCs of 0.795 and 0.768 in the internal and external validation sets, respectively. Combining intratumoral and peritumoral multiparameter models further improved performance, achieving internal AUCs of 0.814, 0.863, and 0.988 and external AUCs of 0.898, 0.774, and 0.812 for AIS, MIA, and IAC, respectively.
conclusionsThe combination of intratumoral and peritumoral multiparametric radiomics derived from SDCT may enhance the noninvasive differentiation of LUAD presenting as GGNs, potentially serving as a valuable tool for supporting clinical decision-making.
Indexed as
Identifiers
42295586What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.